[Autosomal dominant hypophosphatemic rickets/osteomalacia].
Tanaka H.
Nihon Rinsho. 2005 Oct;63 Suppl 10:529-33.
Tumor-induced osteomalacia.
Yin Z, Du J, Yu F, Xia W.
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
Hypophosphatemic rickets.
Jagtap VS, Sarathi V, Lila AR, Bandgar T, Menon P, Shah NS.
Indian J Endocrinol Metab. 2012 Mar;16(2):177-82. doi: 10.4103/2230-8210.93733.
Hypophosphatemic rickets and osteomalacia.
de Menezes Filho H, de Castro LC, Damiani D.
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):802-13. doi: 10.1590/s0004-27302006000400025.
Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.
Econs MJ, McEnery PT.
J Clin Endocrinol Metab. 1997 Feb;82(2):674-81. doi: 10.1210/jcem.82.2.3765.
Phosphatonins: From Discovery to Therapeutics.
Kritmetapak K, Kumar R.
Endocr Pract. 2023 Jan;29(1):69-79. doi: 10.1016/j.eprac.2022.09.007. Epub 2022 Oct 7.
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia.
Ito N, Hidaka N, Kato H.
Endocrinol Metab (Seoul). 2024 Apr;39(2):255-261. doi: 10.3803/EnM.2023.1908. Epub 2024 Mar 11.
Autosomal Dominant Hypophosphatemic Rickets Presenting in a Phenotypically Normal Adult Female.
Mualla H, Bae SA, Yaqub A.
Case Rep Endocrinol. 2019 Mar 4;2019:8917519. doi: 10.1155/2019/8917519. eCollection 2019.
Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia.
Högler W, Kapelari K.
J Bone Miner Res. 2020 Feb;35(2):226-230. doi: 10.1002/jbmr.3941. Epub 2019 Dec 31.
Autosomal dominant hypophosphatemic rickets: a case report of two sisters with a novel FGF-23 mutation.
Mumbach G, Florenzano P, Quinteros J, Ávila C, Zanchetta MB.
Osteoporos Int. 2025 Nov;36(11):2337-2341. doi: 10.1007/s00198-025-07640-9. Epub 2025 Jul 31.
